{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,31]],"date-time":"2026-10-31T02:33:24Z","timestamp":1793414004494,"version":"4.5.0"},"reference-count":38,"publisher":"Elsevier BV","issue":"11","license":[{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,7,7]],"date-time":"2025-07-07T00:00:00Z","timestamp":1751846400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100005492","name":"Stanford University","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100005492","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100006093","name":"Patient-Centered Outcomes Research Institute","doi-asserted-by":"publisher","award":["PPRN-1501\\u201326848"],"award-info":[{"award-number":["PPRN-1501\\u201326848"]}],"id":[{"id":"10.13039\/100006093","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["aacejournalendocrinepractice.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Endocrine Practice"],"published-print":{"date-parts":[[2025,11]]},"DOI":"10.1016\/j.eprac.2025.06.028","type":"journal-article","created":{"date-parts":[[2025,7,7]],"date-time":"2025-07-07T02:05:36Z","timestamp":1751853936000},"page":"1449-1461","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":6,"title":["Progestogen Experience Among Transgender Women and Gender Diverse Adults Assigned Male at Birth in the United States"],"prefix":"10.1016","volume":"31","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-2043-1129","authenticated-orcid":false,"given":"Julia J.","family":"Chang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nguyen Khai","family":"Tran","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Annesa","family":"Flentje","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Micah E.","family":"Lubensky","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juno","family":"Obedin-Maliver","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mitchell R.","family":"Lunn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Danit","family":"Ariel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"11","key":"10.1016\/j.eprac.2025.06.028_bib1","doi-asserted-by":"crossref","first-page":"3869","DOI":"10.1210\/jc.2017-01658","article-title":"Endocrine treatment of gender-dysphoric\/gender-incongruent persons: an Endocrine Society Clinical Practice Guideline","volume":"102","author":"Hembree","year":"2017","journal-title":"J Clin Endocrinol Metab"},{"issue":"suppl 1","key":"10.1016\/j.eprac.2025.06.028_bib2","doi-asserted-by":"crossref","first-page":"S1","DOI":"10.1080\/26895269.2022.2100644","article-title":"Standards of care for the health of transgender and gender diverse people, Version 8","volume":"23","author":"Coleman","year":"2022","journal-title":"Int J Transgender Health"},{"issue":"4","key":"10.1016\/j.eprac.2025.06.028_bib3","doi-asserted-by":"crossref","first-page":"1181","DOI":"10.1210\/jc.2018-01777","article-title":"Progesterone is important for transgender women\u2019s therapy-applying evidence for the benefits of progesterone in ciswomen","volume":"104","author":"Prior","year":"2019","journal-title":"J Clin Endocrinol Metab"},{"issue":"5","key":"10.1016\/j.eprac.2025.06.028_bib4","doi-asserted-by":"crossref","first-page":"1240","DOI":"10.1111\/jsm.12487","article-title":"Clinical review: breast development in trans women receiving cross-sex hormones","volume":"11","author":"Wierckx","year":"2014","journal-title":"J Sex Med"},{"issue":"2","key":"10.1016\/j.eprac.2025.06.028_bib5","doi-asserted-by":"crossref","first-page":"532","DOI":"10.1210\/jc.2017-01927","article-title":"Breast development in transwomen after 1 year of cross-sex hormone therapy: results of a prospective multicenter study","volume":"103","author":"de Blok","year":"2018","journal-title":"J Clin Endocrinol Metab"},{"issue":"12","key":"10.1016\/j.eprac.2025.06.028_bib6","doi-asserted-by":"crossref","first-page":"1338","DOI":"10.4158\/EP-2019-0183","article-title":"A review of breast development in cisgender women and implications for transgender women","volume":"25","author":"Reisman","year":"2019","journal-title":"Endocr Pract"},{"issue":"8","key":"10.1016\/j.eprac.2025.06.028_bib7","doi-asserted-by":"crossref","first-page":"3467","DOI":"10.1210\/jc.2002-021967","article-title":"Endocrine treatment of transsexual people: a review of treatment regimens, outcomes, and adverse effects","volume":"88","author":"Moore","year":"2003","journal-title":"J Clin Endocrinol Metab"},{"issue":"8","key":"10.1016\/j.eprac.2025.06.028_bib8","doi-asserted-by":"crossref","first-page":"3129","DOI":"10.1210\/jc.2019-00524","article-title":"Response to Letter to the Editor: \u201cProgesterone is important for transgender women\u2019s therapy-applying evidence for the benefits of progesterone in ciswomen.\u201d","volume":"104","author":"Prior","year":"2019","journal-title":"J Clin Endocrinol Metab"},{"issue":"8","key":"10.1016\/j.eprac.2025.06.028_bib9","doi-asserted-by":"crossref","first-page":"3127","DOI":"10.1210\/jc.2019-00249","article-title":"Letter to the editor: \u201cProgesterone is important for transgender women\u2019s therapy-applying evidence for the benefits of progesterone in ciswomen\u201d","volume":"104","author":"Iwamoto","year":"2019","journal-title":"J Clin Endocrinol Metab"},{"issue":"12","key":"10.1016\/j.eprac.2025.06.028_bib10","doi-asserted-by":"crossref","first-page":"1244","DOI":"10.1016\/j.eprac.2022.08.012","article-title":"Progestogen use in gender-affirming hormone therapy: a systematic review","volume":"28","author":"Patel","year":"2022","journal-title":"Endocr Pract"},{"issue":"5","key":"10.1016\/j.eprac.2025.06.028_bib11","doi-asserted-by":"crossref","DOI":"10.1530\/EC-22-0170","article-title":"Effects of low-dose oral micronised progesterone on sleep, psychological distress, and breast development in transgender individuals undergoing feminising hormone therapy: a prospective controlled study","volume":"11","author":"Nolan","year":"2022","journal-title":"Endocr Connect"},{"issue":"2","key":"10.1016\/j.eprac.2025.06.028_bib12","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1007\/BF01542220","article-title":"Physical and hormonal evaluation of transsexual patients: a longitudinal study","volume":"15","author":"Meyer","year":"1986","journal-title":"Arch Sex Behav"},{"issue":"3","key":"10.1016\/j.eprac.2025.06.028_bib13","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1001\/jama.288.3.321","article-title":"Risks and benefits of estrogen plus progestin in healthy postmenopausal women: principal results from the Women\u2019s Health Initiative randomized controlled trial","volume":"288","author":"Rossouw","year":"2002","journal-title":"JAMA"},{"issue":"7","key":"10.1016\/j.eprac.2025.06.028_bib14","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1038\/ncpcardio1234","article-title":"Cardiovascular effects of medroxyprogesterone acetate and progesterone: a case of mistaken identity?","volume":"5","author":"Hermsmeyer","year":"2008","journal-title":"Nat Clin Pract Cardiovasc Med"},{"issue":"1","key":"10.1016\/j.eprac.2025.06.028_bib15","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1007\/s10549-007-9523-x","article-title":"Unequal risks for breast cancer associated with different hormone replacement therapies: results from the E3N cohort study","volume":"107","author":"Fournier","year":"2008","journal-title":"Breast Cancer Res Treat"},{"issue":"11","key":"10.1016\/j.eprac.2025.06.028_bib16","doi-asserted-by":"crossref","first-page":"5148","DOI":"10.1210\/jc.2018-02253","article-title":"Medroxyprogesterone acetate in gender-affirming therapy for transwomen: results from a retrospective study","volume":"104","author":"Jain","year":"2019","journal-title":"J Clin Endocrinol Metab"},{"issue":"1","key":"10.1016\/j.eprac.2025.06.028_bib17","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1016\/j.japh.2023.08.001","article-title":"Effects of progesterone on gender affirmation outcomes as part of feminizing hormone therapy","volume":"64","author":"Bahr","year":"2024","journal-title":"J Am Pharm Assoc"},{"issue":"8-9","key":"10.1016\/j.eprac.2025.06.028_bib18","doi-asserted-by":"crossref","first-page":"737","DOI":"10.1093\/jamia\/ocz082","article-title":"A digital health research platform for community engagement, recruitment, and retention of sexual and gender minority adults in a national longitudinal cohort study\u2014the PRIDE study","volume":"26","author":"Lunn","year":"2019","journal-title":"J Am Med Inform Assoc"},{"issue":"2","key":"10.1016\/j.eprac.2025.06.028_bib19","doi-asserted-by":"crossref","first-page":"9","DOI":"10.54656\/jces.v16i2.484","article-title":"Engaging sexual and gender minority (SGM) communities for health research: building and sustaining PRIDEnet","volume":"16","author":"Obedin-Maliver","year":"2024","journal-title":"J Community Engagem Scholarsh"},{"key":"10.1016\/j.eprac.2025.06.028_bib22","series-title":"Qualitative Data Analysis: A Methods Sourcebook","author":"Miles","year":"2020"},{"issue":"6","key":"10.1016\/j.eprac.2025.06.028_bib23","first-page":"443","article-title":"Bioavailability of progesterone with different modes of administration","volume":"32","author":"Chakmakjian","year":"1987","journal-title":"J Reprod Med"},{"issue":"2","key":"10.1016\/j.eprac.2025.06.028_bib24","doi-asserted-by":"crossref","first-page":"e782","DOI":"10.1210\/clinem\/dgaa841","article-title":"Sustained breast development and breast anthropometric changes in 3 years of gender-affirming hormone treatment","volume":"106","author":"De Blok","year":"2021","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.eprac.2025.06.028_bib25","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1016\/j.bpobgyn.2020.04.001","article-title":"Progesterone and breast","volume":"69","author":"Lamb","year":"2020","journal-title":"Best Pract Res Clin Obstet Gynaecol"},{"issue":"1","key":"10.1016\/j.eprac.2025.06.028_bib26","doi-asserted-by":"crossref","first-page":"T81","DOI":"10.1530\/JME-20-0091","article-title":"90 years of progesterone: progesterone receptor signaling in the normal breast and its implications for cancer","volume":"65","author":"Brisken","year":"2020","journal-title":"J Mol Endocrinol"},{"issue":"2","key":"10.1016\/j.eprac.2025.06.028_bib27","first-page":"22","article-title":"Progestin-related breast volume changes in a woman with complete androgen insensitivity syndrome (CAIS)","volume":"2023","author":"Dijkman","year":"2023","journal-title":"Endocrinol Diabetes Metab Case Rep"},{"issue":"6","key":"10.1016\/j.eprac.2025.06.028_bib28","doi-asserted-by":"crossref","first-page":"G53","DOI":"10.1093\/ejendo\/lvae050","article-title":"Clinical practice guidelines for the care of girls and women with Turner syndrome","volume":"190","author":"Gravholt","year":"2024","journal-title":"Eur J Endocrinol"},{"issue":"2","key":"10.1016\/j.eprac.2025.06.028_bib29","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1001\/jamapsychiatry.2017.3998","article-title":"Efficacy of transdermal estradiol and micronized progesterone in the prevention of depressive symptoms in the menopause transition: a randomized clinical trial","volume":"75","author":"Gordon","year":"2018","journal-title":"JAMA Psychiatry"},{"key":"10.1016\/j.eprac.2025.06.028_bib30","doi-asserted-by":"crossref","DOI":"10.1016\/j.psyneuen.2024.107223","article-title":"Investigating the association between hair progesterone, anxiety, sleep quality, and other determinants in South African females","volume":"171","author":"Kew","year":"2025","journal-title":"Psychoneuroendocrinology"},{"key":"10.1016\/j.eprac.2025.06.028_bib31","doi-asserted-by":"crossref","DOI":"10.1016\/j.psyneuen.2019.104382","article-title":"Do dehydroepiandrosterone, progesterone, and testosterone influence women\u2019s depression and anxiety levels? Evidence from hair-based hormonal measures of 2105 rural Indian women","volume":"109","author":"Walther","year":"2019","journal-title":"Psychoneuroendocrinology"},{"issue":"4","key":"10.1016\/j.eprac.2025.06.028_bib32","doi-asserted-by":"crossref","first-page":"942","DOI":"10.1210\/clinem\/dgaa873","article-title":"Efficacy of micronized progesterone for sleep: a systematic review and meta-analysis of randomized controlled trial data","volume":"106","author":"Nolan","year":"2021","journal-title":"J Clin Endocrinol Metab"},{"issue":"8","key":"10.1016\/j.eprac.2025.06.028_bib33","doi-asserted-by":"crossref","DOI":"10.1002\/cbf.70025","article-title":"A recent update on the role of estrogen and progesterone in Alzheimer\u2019s disease","volume":"42","author":"Suganya","year":"2024","journal-title":"Cell Biochem Funct"},{"issue":"4","key":"10.1016\/j.eprac.2025.06.028_bib34","doi-asserted-by":"crossref","first-page":"636","DOI":"10.1016\/j.yhbeh.2013.02.013","article-title":"Hormonal predictors of sexual motivation in natural menstrual cycles","volume":"63","author":"Roney","year":"2013","journal-title":"Horm Behav"},{"issue":"3","key":"10.1016\/j.eprac.2025.06.028_bib35","doi-asserted-by":"crossref","first-page":"454","DOI":"10.1097\/GRF.0000000000000364","article-title":"Differential effects of progestogens used for menopausal hormone therapy","volume":"61","author":"Van Heertum","year":"2018","journal-title":"Clin Obstet Gynecol"},{"issue":"5","key":"10.1016\/j.eprac.2025.06.028_bib36","doi-asserted-by":"crossref","first-page":"e2050","DOI":"10.1210\/clinem\/dgz262","article-title":"The effect of perimenopausal transdermal estradiol and micronized progesterone on markers of risk for arterial disease","volume":"105","author":"Gordon","year":"2020","journal-title":"J Clin Endocrinol Metab"},{"issue":"7","key":"10.1016\/j.eprac.2025.06.028_bib37","doi-asserted-by":"crossref","first-page":"840","DOI":"10.1161\/CIRCULATIONAHA.106.642280","article-title":"Hormone therapy and venous thromboembolism among postmenopausal women: impact of the route of estrogen administration and progestogens: the ESTHER study","volume":"115","author":"Canonico","year":"2007","journal-title":"Circulation"},{"issue":"7","key":"10.1016\/j.eprac.2025.06.028_bib38","doi-asserted-by":"crossref","first-page":"2047","DOI":"10.1093\/brain\/awy108","article-title":"The occurrence of benign brain tumours in transgender individuals during cross-sex hormone treatment","volume":"141","author":"Nota","year":"2018","journal-title":"Brain"},{"issue":"6","key":"10.1016\/j.eprac.2025.06.028_bib39","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1089\/trgh.2021.0025","article-title":"Development and growth of intracranial meningiomas in transgender women taking cyproterone acetate as gender-affirming progestogen therapy: a systematic review","volume":"7","author":"Millward","year":"2022","journal-title":"Transgend Health"},{"issue":"1","key":"10.1016\/j.eprac.2025.06.028_bib40","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1186\/s40360-023-00724-4","article-title":"Addition of progesterone to feminizing gender-affirming hormone therapy in transgender individuals for breast development: a randomized controlled trial","volume":"24","author":"Dijkman","year":"2023","journal-title":"BMC Pharmacol Toxicol"}],"container-title":["Endocrine Practice"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1530891X25009437?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1530891X25009437?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,1,14]],"date-time":"2026-01-14T23:39:27Z","timestamp":1768433967000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1530891X25009437"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11]]},"references-count":38,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2025,11]]}},"alternative-id":["S1530891X25009437"],"URL":"https:\/\/doi.org\/10.1016\/j.eprac.2025.06.028","relation":{},"ISSN":["1530-891X"],"issn-type":[{"value":"1530-891X","type":"print"}],"subject":[],"published":{"date-parts":[[2025,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Progestogen Experience Among Transgender Women and Gender Diverse Adults Assigned Male at Birth in the United States","name":"articletitle","label":"Article Title"},{"value":"Endocrine Practice","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.eprac.2025.06.028","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 AACE. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}